Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (procedure)
SCTID: 1157108008, Primitive, Active
1157108008|Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (procedure)|
- en Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein
- en Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (procedure)
- en Second severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccination
- en Administration of second dose sars-cov-2 non-replicating viral vector vaccine
- en Second 2019-ncov non-replicating viral vector immunisation
- en Second 2019-ncov non-replicating viral vector immunization
- en Second 2019-ncov non-replicating viral vector vaccination
- en Second 2019 novel coronavirus non-replicating viral vector immunisation
- en Second 2019 novel coronavirus non-replicating viral vector immunization
- en Second 2019 novel coronavirus non-replicating viral vector vaccination
- en Second covid-19 non-replicating viral vector immunisation
- en Second covid-19 non-replicating viral vector immunization
- en Second covid-19 non-replicating viral vector vaccination
- en Second sars-cov-2 non-replicating viral vector immunisation
- en Second sars-cov-2 non-replicating viral vector immunization
- en Second sars-cov-2 non-replicating viral vector vaccination